GALT

Conviction 73HealthcareScan · Thu, Jun 25, 2026

GALT$4.24+8.04%

ResistanceSupportVol 14Insider sell

Vol MA14 726.62K

Mar 26Apr 14May 1May 19Jun 8Jun 25

GALECTIN THERAPEUTICS INCPHARMACEUTICAL PREPARATIONSwww.galectintherapeutics.com ↗

Price4.24

Change+8.04%

Gap+2.04%

Rel volume2.03×

Avg volume587.13K

Avg $ vol1.85M

SMA 202.73

SMA 502.48

SMA 2003.72

Price vs 50+70.45%

Price vs 200+13.71%

MA stackmixed

50/200 cross—

Supertrendup · 3.06

RSI (14)85

MACD hist0.16

MACD crossbull · 9d

Stoch %K / %D94 / 83

ADX (14)34

+DI / −DI45 / 7

RSI divergence—

MACD divergence—

ATR %+7.40%

ADR %9.61%

52w high6.51

52w low2.08

From 52w high-34.95%

Above 52w low+103.61%

New 52w highNo

SqueezeOff

Bollinger width72.01%

%B1.27

Donchian pos93.84%

Donchian high4.37

Donchian low2.26

AVWAP (52w high)3.19

vs AVWAP high+32.97%

AVWAP (52w low)2.88

vs AVWAP low+46.85%

OBV trendUp

Chaikin MF (20)0.06

Today vs 20d2.03×

Avg vol (14d)726.62K

Avg vol (20d)587.13K

Avg $ vol (20d)1.85M

Market cap278.9M

RS 3m (vs SPY)+26.26%

RS 6m (vs SPY)-18.24%

RS line new highYes

Trend template4/8

Technical rank80.6

1 week+52.89%

1 month+51.79%

3 months+44.54%

6 months+5.09%

1 year+75.00%

YTD+4.57%

P/E-9.04

P/B-2.11

P/S—

P/FCF-11.68

EPS-0.4800

Div yield—

ROE23.37%

ROA-195.67%

Debt/Eq—

Current2.15

EV/EBITDA-13.18

Gross margin—

Net margin—

Rev growth—

EPS growth34.46%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value264.79M

Revenue—

Net income-5.05M

Gross profit—

Free cash flow-23.88M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out65.86M

Employees9

ListedWed, Sep 4, 2002

Free float43.66M

Float %66.3%

Short interest7.66M

Days to cover19.7d

Short volume44.5%

Squeeze score78 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction73 / 100

Pattern quality—

Tech rank80.6 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.76

Support2.05

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in GALT

All disclosures →

No recent disclosed trades by Congress in GALT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GALT · 2 buys · 4 sells

Insider	Side	Shares	Value	Traded	Filed
Jamil Khurram Chief Medical Officer · Common Stock · 2026-06-23	Exercise	7.56K	$9K	2026-06-23	2026-06-25
Jamil Khurram Chief Medical Officer · Common Stock · 2026-06-23	Sell	7.56K	$24K	2026-06-23	2026-06-25
Jamil Khurram Chief Medical Officer · Stock option (right to buy) · 2026-06-23	Exercise	7.56K	—	2026-06-23	2026-06-25
Jamil Khurram Chief Medical Officer · Stock option (right to buy) · 2026-05-26	Exercise	568	$0	2026-05-26	2026-05-28
Jamil Khurram Chief Medical Officer · Common Stock · 2026-05-26	Exercise	568	$699	2026-05-26	2026-05-28
Jamil Khurram Chief Medical Officer · Common Stock · 2026-05-26	Sell	568	$2K	2026-05-26	2026-05-28

SEC filings

EDGAR filings in GALT · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.